JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266206

Human PPP4R2 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

PPP4R2 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 1 and 1 bp insertion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human PPP4R2 knockout HEK-293T cell line (AB266206)
  • Sanger seq

Unknown

Sanger Sequencing - Human PPP4R2 knockout HEK-293T cell line (AB266206)

Allele-2 : 1 bp insertion in exon 1.

Sanger Sequencing - Human PPP4R2 knockout HEK-293T cell line (AB266206)
  • Sanger seq

Unknown

Sanger Sequencing - Human PPP4R2 knockout HEK-293T cell line (AB266206)

Allele-1 : 10 bp deletion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 1 and 1 bp insertion in exon 1

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266206-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266206 Human PPP4R2 knockout HEK-293T cell line", "number":"AB266206-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266206-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266206-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266206-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266206 Human PPP4R2 knockout HEK-293T cell line", "number":"AB266206-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266206-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266206 Human PPP4R2 knockout HEK-293T cell line", "number":"AB266206-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266206-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266206 Human PPP4R2 knockout HEK-293T cell line", "number":"AB266206-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
PPP4R2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein phosphatase 4 regulatory subunit 2 commonly known as PPP4R2 serves as a regulatory subunit in the protein phosphatase 4 (PP4) complex. It has an approximate mass of 50 kDa. PPP4R2 is mainly expressed in the cytoplasm of cells where it regulates the activity and specificity of PP4. It is involved in various cellular processes due to its capacity to modulate PP4's activity.
Biological function summary

PPP4R2 plays a significant role in DNA damage repair processes. PPP4R2 is part of the PP4 complex and together with other components it oversees dephosphorylation processes post DNA damage which is essential for cell cycle progression and genomic stability. It collaborates with other proteins in the complex to ensure accurate DNA repair maintaining proper cellular function and preventing mutations.

Pathways

PPP4R2 is notably involved in the DNA repair pathway and cell cycle regulation pathway. These pathways are critical for maintaining cell integrity and viability. Within the DNA repair pathway PPP4R2 operates closely with proteins like PP4C the catalytic subunit of PP4 which performs dephosphorylation tasks essential for DNA damage response. In the cell cycle regulation pathway PPP4R2 ensures appropriate cell cycle checkpoints by interacting with multiple cellular proteins which helps in maintaining genomic stability.

Research links PPP4R2 to cancer and neurodegenerative diseases highlighting its importance in maintaining genomic integrity. In cancer alterations in PPP4R2 expression or function can affect DNA repair leading to genomic instability and tumorigenesis. PPP4R2 interacts with proteins such as CHK2 that are important in the DNA damage response. Moreover abnormal PPP4R2 activity impacts neurodegenerative conditions where defects in DNA repair mechanisms are implicated. Understanding its role in these contexts aids in potential therapeutic targeting strategies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com